Valuation of the largest companies in the same industry.
Industry median 0.98x
4.23x01276HENGRUI PHARMA
2.76x01672ASCLETIS-B
2.76x01167JACOBIO-B
2.65x01177SBP GROUP
2.39x01093CSPC PHARMA
0x2x4x6x8x
Industry comparison
Distribution of companies by valuation in the industry, with the expected growth of next fiscal year earnings.
Industry median 0.98x
0.00x1.00x2.00x3.00x4.00x
Current valuation
1.57xP/S
HK$22.16Share price
HK$14.12Revenue per share
Valuation history
P/SFair rangeMedian
P/S
1.73x
Fair range
1.59x–1.93x
Peer comparison
Valuation of the largest companies in the same industry.
Industry median 2.20x
6629.97x01672ASCLETIS-B
113.11x00399STARCOIN GROUP
17.63x01228CANBRIDGE-B
17.63x01011NT PHARMA
8.70x01276HENGRUI PHARMA
0x1,658x3,316x4,974x6,632x
Industry comparison
Distribution of companies by valuation in the industry, with the expected growth of next fiscal year earnings.
Industry median 2.20x
0.00x2,000.00x4,000.00x6,000.00x
Current valuation
7.48%Dividend yield
HK$22.16Share price
HK$1.66Dividend per share
Valuation history
Dividend yieldFair rangeMedian
Dividend yield
5.73%
Fair range
4.99%–6.94%
Peer comparison
Valuation of the largest companies in the same industry.
Industry median 4.21%
7.48%01513LIVZON PHARMA
7.11%00239PAK FAH YEOW
6.85%01666TONG REN TANG
5.58%01061ESSEX BIO-TECH
5.25%01681CONSUN PHARMA
0x2x4x6x8x
Industry comparison
Distribution of companies by valuation in the industry, with the expected growth of next fiscal year earnings.
Industry median 4.21%
0.00%2.00%4.00%6.00%
About this page
This page shows LIVZON PHARMA (01513) on four valuation measures - P/E, P/B, P/S and dividend yield: the current value, the per-share input, 1/3/5/10-year valuation history with its fair range, peer comparison within the same sub-industry, and the industry distribution. Per-share figures come from disclosed statements divided by the shares in issue that month, and each historical point uses the close of that day against the statements published by then.